Menarini Silicon Biosystems, INC clinical trials
Acquired by Menarini Group, 2013 · source ↗
The registry lists 3 studies whose lead sponsor is Menarini Silicon Biosystems, INC. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 5, 2026.
Before and after it joined Menarini Group
- First submitted before Menarini Silicon Biosystems, INC became part of Menarini Group
- 0
- First submitted after Menarini Silicon Biosystems, INC became part of Menarini Group
- 3
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Menarini Silicon Biosystems, INC2 studies
- Menarini Silicon Biosystems1 study
Something wrong with this grouping? Tell us on the Menarini Group page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Menarini Group studies →
- Cell-based Non-invasive Prenatal Test WorkflowNot yet recruitingNCT07566780
Sponsor listed in the registry: Menarini Silicon Biosystems · First submitted after Menarini Silicon Biosystems became part of Menarini Group
- A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer PatientsRecruitingNCT06833853
Sponsor listed in the registry: Menarini Silicon Biosystems, INC · First submitted after Menarini Silicon Biosystems, INC became part of Menarini Group
- ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)Active, not recruitingNCT05662345
Sponsor listed in the registry: Menarini Silicon Biosystems, INC · First submitted after Menarini Silicon Biosystems, INC became part of Menarini Group